HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

BGLC

BioNexus Gene Lab Corp. (NASDAQ)

Basic Materials — Specialty Chemicals

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

None
$1.54
$-0.09 (-5.52%)
Sign in to add BGLC to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$4.83M
P/E Ratio (TTM)-
Forward P/E-
EPS (TTM)$-1.49
Dividend Yield-
Profit Margin-54.70%
Revenue Growth-98.90%
ROE-36.62%
Debt/Equity4.28
Recommendation None
Analyst Target-
Analysts-
Indexes NASDAQ

Technical Indicators

RSI (14)51.0
Beta2.19
SMA 20-
SMA 40-
52-Week High$8.98
52-Week Low$1.07
50-Day Avg$2.16
200-Day Avg$3.37
Avg Volume100.9K
Volume9.6K

Performance Analysis

BEARISH

BGLC is flashing more cautionary signals — investors should monitor closely.

+ Trading near its 52-week low ($1.07), which could present a value opportunity.
~ RSI at 51.0 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- Revenue declined 98.9% year-over-year.
- Operating at a loss with -54.7% margin.
~ Wall Street consensus is "none".

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 12:59 UTC

Back to Screener Export Report